med vet L32
Page 1: Contents Overview
INDEX: Lists of various topics and discussions about science, notable events, and theories.
Highlighted Entries:
How Science Works
How Google Works
Outrageous headlines from WEEKLY WORLD.
Page 2: The Flat Earth Society
Mission: Promote discussions on Flat Earth theory and archive related literature.
Goals:
Encourage free thinking and debate.
Challenge 'Globularist' ideas.
Public Figure Mention: Kyrie Irving expresses uncertainty about the Earth's shape, seeking discussions on the topic.
Page 3: Vaccine Efficacy
Definition: Efficacy viewed as the capacity of a vaccine to eliminate infection.
Realistic Expectations: Most vaccines do not provide sterilizing immunity.
Performance Metrics: FDA/USDA measures include:
Reduction in symptoms.
Reduction in deaths and transmission.
Goal: Achieve population immunity to control diseases.
Page 4: COVID-19 Death Rates by Vaccination Status
Overview: Death rates calculated per 100,000 people based on vaccination status.
Data Visualization: Comparison of death rates among unvaccinated, vaccinated with bivalent booster, and vaccinated without.
Source: Centers for Disease Control and Prevention data on mortality rates.
Page 5: Prophylactic Vaccines
Purpose: Protect against disease rather than infection.
Characteristics:
Considered one of the best defenses against diseases.
Safe with
adverse reactionsweighed against disease risks.
Page 6: Immune System Overview
Components:
Humoral Immune System
Cellular Immune System
Key Cells:
Neutrophils, macrophages, killer cells, natural killer cells, helper T cells, cytotoxic T cells.
Function: Responds to invading microbes.
Page 7: Immune Responses in Vaccinates vs. Unvaccinated
Comparison: Responses vary between vaccinated and unvaccinated individuals when exposed to pathogens.
Memory Cell Generation: Vaccinated individuals develop memory cells and antibodies more effectively.
Primary vs. Secondary Response: Secondary response eliminates pathogens more rapidly compared to primary response.
Page 8: Types of Immunity - Active vs. Passive
Active Immunity: Generated by the individual (e.g., through vaccination).
Passive Immunity: Introduced from an external source (e.g., monoclonal antibodies).
Examples: Moderna, Pfizer, J&J vaccines for active; Regeneron for passive.
Page 9: Immunologic Memory
Cellular Immunity: Responsible for maintaining memory of previous infections or vaccinations.
Graph Data: Depicts changes in serum antibodies over time post-vaccination.
Page 10: Infectious Diseases Overview
Definitions:
Emerging: Newly observed diseases (e.g., HIV).
Re-emerging: Old diseases resurfacing (e.g., TB).
Causes: Often linked to globalization and interactions between humans and wildlife.
Page 11: Recent Noteworthy Infectious Diseases
Emerging Diseases:
Ebola, Legionnaires’ disease, SARS, West Nile virus, Pandemic Influenza, MERS, Zika virus.
Notable Dates: Listed respective years of emergence.
Page 12: Reasons for Disease Re-emergence
Factors:
Combinations of diseases (e.g., HIV and TB).
Improper antibiotic use leading to drug-resistant infections.
Laxity in vaccination programs leading to outbreaks.
Page 13: Characteristics of Successful Vaccines
Key Features:
Efficacy measured by stimulating immune response.
Coverage: 80-95% of the population.
Safety: Should not cause diseases, with acceptable side effects.
Page 14: Vaccine Effectiveness
Effectiveness Metrics: Most vaccines have an efficacy rate of 80-95%.
Antigen Requirements: Protective epitopes need to be included for best results.
Page 15: Malaria Vaccine Challenges
P. falciparum Life Cycle: Complexity due to multiple target stages within human hosts.
Transmission Pathway: How sporozoites transfer from mosquitos to humans and their replication cycle.
Page 16: Herd Immunity
Definition: Sufficient immune proportion in a population makes disease spread unlikely.
Community Protection: Benefits even those not vaccinated.
Terminology: Known as community immunity or cocooning.
Page 17: Herd Immunity Dynamics
Illustration of Spread: How different immunity levels affect contagious diseases spreading through populations.
Epidemiological Concepts: Visualizes disease spread in immunized vs. non-immunized groups.
Page 18: Basic Reproduction Number (R)
Concept Overview: Understanding basic reproduction number R (e.g., R=3).
Page 19: Herd Immunity Thresholds
Vaccine-Preventable Diseases: Comparison of immunization levels for various diseases.
Data Presentation: Herd immunity thresholds based on R0 values.
Page 20: Vaccine Safety and Efficacy Trials
Regulatory Oversight: FDA monitors phases of clinical trials.
Adverse Event Reports: Importance of monitoring vaccine outcomes post-licensure.
Page 21: Vaccine Targeting
Strategies: All vaccine types target specific components of pathogens to limit infections.
Page 22: Immune System Mechanism
Cytotoxic Mechanism: How T cells attack infected cells using perforin to lyse membranes.
Page 23: Molecular Pathways in Vaccines
Vaccine Targeting: DNA transcription in cells leading to protein synthesis in the immune response.
Page 24: Types of Vaccines: Overview
Categorization: Different types of vaccines (live, killed, subunit etc.) based on their action and response.
Key Considerations: Efficacy vs safety.
Page 25: Vaccine Types Recap
Detailed Coverage: Description of various vaccine types and their regulatory oversight.
Page 26: Traditional Vaccine Methods
Example Vaccines: Live & Killed formulations.
Page 27: Modified-Live Vaccines
Methodology: Attenuation techniques for vaccine development.
Page 28: Advantages and Disadvantages of Modified-Live Vaccines
Pros: Quick immunity development, fewer doses needed.
Cons: Risk of reversion and need for proper storage conditions.
Page 29: Inactivated Vaccines
Production Characteristics: Methods leading to non-replicating targets.
Page 30: Inactivated Vaccine Pros & Cons
Advantages: Safety, longevity, stability.
Disadvantages: More costly, potential for less response.
Page 31: Toxoid Vaccines
Functionality: Inactivated toxins used for immunity.
Page 32: Subunit Vaccines
Description: Use of prominent proteins from pathogens for immunity development.
Page 33: Recombinant Virus Vaccines
Process: Using recombinant techniques to elicit immune responses.
Page 34: DNA Vaccination Evolution
Characteristics: How DNA vaccines work as a varied form of the subunit approach.
Page 35: DNA Vaccine Structure
Components: Eukaryotic promoter plus important sequences for antigen presentation.
Page 36: Advantages of DNA Vaccination
Benefits: Cost-effectiveness, stability, immune response capabilities.
Page 37: Safety Concerns of DNA Vaccines
Risks: Potential for adverse effects like tumor induction.
Page 38: Role of Adjuvants
Function: Enhancing immune response effectiveness in vaccines.
Page 39: Diversified Adjuvant Strategies
Types of Adjuvants: Various delivery vehicles to enhance antigen uptake.
Page 40: Optimal Adjuvant Characteristics
Attributes: Aimed to activate specific immune response elements while minimizing overshooting reactions.
Page 41: Aluminum-Based Adjuvants
Usage Overview: Commonly used in vaccines including examples and their effects on immune responses.
Page 42: Lipid and Oil Emulsion Adjuvants
Functionality: Used to stabilize antigens and enhance MHC responses.
Page 43: Oil-Based Adjuvant Advantages
Types of Emulsions: Various formats used in vaccine formulations, such as Water-in-Oil.
Page 44: W/O/W Adjuvant System Structure
Components: Introduction to the adjuvant configuration and its components.
Page 45: Pathogen Recognition Receptors (PRR)
Responses: Various receptors involved in immune response activation.
Page 46: Delivery Mechanisms for Vaccines
Description: Liposomal formulations and other sophisticated methods to enhance immunogenicity.
Page 47: Vaccine Side Effects
Common Reactions: Overview of typical adverse reactions and myths surrounding vaccines.
Page 48: Future Directions in Vaccination
Focus Areas: Research and development towards new prophylactic and therapeutic vaccines.
Page 49: Vaccine Categories Summary
Vaccine Types: Overview of whole organism, subunit, DNA, adjuvants, and their effectiveness.
Page 50: Vaccine Pros and Cons Table
Detailing Characteristics: Advantages and disadvantages of different vaccine types in-depth.
Page 51: Upcoming Discussions
Next Topics: Further exploration of vaccine mechanisms of action.